07:58 AM EDT, 07/25/2024 (MT Newswires) -- Aurora Cannabis ( ACB ) , a medical cannabis company, said Thursday it has been granted two licenses by the Federal Institute for Drugs and Medical Devices under Germany's new Medical Cannabis Act.

The license grants the company continued domestic cultivation, which has been underway for two years. The new license allows Aurora to cultivate an approved additional product. Aurora will also receive a dedicated R&D license, allowing for the trial of up to seven additional novel cultivars at its local facility in Leuna, Germany.

Since 2021, Aurora's medical cannabis production facility in Leuna, Saxony-Anhalt, has been cultivating approximately 1,000 kg of medical cannabis flower annually as part of a tender agreement with the German government.